Posts With Tag NASDAQ FHTX

Explore Foghorn Therapeutics Inc.'s 8-K filing, revealing significant events from January 13, 2025, impacting stock performance. Stay informed on corporate actions and financial developments.

Explore Foghorn Therapeutics Inc.'s 8-K report covering a significant event on December 29, 2024. Learn about its common stock, NASDAQ listing, and corporate transparency.